000 04168nam a22004815i 4500
999 _c200457491
_d75703
003 TR-AnTOB
005 20231109085813.0
007 cr nn 008mamaa
008 220306s2022 si | s |||| 0|eng d
020 _a9789811672002
024 7 _a10.1007/978-981-16-7200-2
_2doi
040 _aTR-AnTOB
_beng
_erda
_cTR-AnTOB
041 _aeng
060 _aWE 544
072 7 _aMJ
_2bicssc
072 7 _aMED083000
_2bisacsh
072 7 _aMJ
_2thema
096 _aWE544EBK
245 1 0 _aHandbook of Biologics for Rheumatological Disorders
_h[electronic resource] /
_cedited by Neeraj Jain, Lalit Duggal.
250 _a1st ed. 2022.
264 1 _aSingapore :
_bSpringer Nature Singapore :
_bImprint: Springer,
_c2022.
300 _a1 online resource
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aHistory of Biologics -- Biologics in Rheumatoid Arthritis -- Biologics in Spondylarthritis -- Biologics in Psoriatic Arthritis -- Biologics in Gout -- Biologics in Lupus -- Biologics in Sjogren’s Syndrome -- Biologics in Systemic Sclerosis -- Biologics in Inflammatory Myopathies -- Biologics in ANCA Associated Vasculitis -- Biologics inBehcet's Syndrome -- Biologicsin Takayasu's Arteritis -- Biologics in Interstitial lung disease in Rheumatological conditions -- Biologics in Osteoporosis -- Biologics in Osteoarthritis -- Biologics in JIA -- Biologics in Paediatric CTD -- JAK inhibitors in Rheumatology -- Biologics in Rheumatic disease with Infections -- Biologics in Rheumatological conditions with Malignancy -- Biologics in Uveitis -- Biologics in Sarcoidosis -- Biologics in IgG4-RD -- Biosimilar in Rheumatology -- Off label use of Biologics in Rheumatological disorders -- Biologics & Ethical issues in Rheumatology -- Patient consent for use of biologics.
520 _aBiologics have revolutionized the treatment of autoimmune diseases due to their efficacy, speed of onset, and tolerability. The development of new agents and expanded use of existing agents continues to be a highly active area of investigation among rheumatic diseases, with a multitude of innovative therapeutic strategies in various stages of development. Although the story of treatments continues rapidly, therapeutic research in some conditions is hindered by the rarity of the disease, variation in phenotype, and concerns about toxicity. This fast-paced development of therapeutics,necessitates immediate evaluation of individual biologic agents and their best use in the new treatment regimens. This book provides an inclusive approach with the existing evidence concerning effectiveness and implications on the usage of biologics in treating various rheumatologic disorders. It also covers the evidence behind the rational use of these agents in varied autoimmune diseases. This manual also offers a complete overview of the existing & futuristic biologic treatments, and draws recommendations on how to standardize the most suitable regimen for a specific patient in the context of current guidelines. The handbook of Biologics in Rheumatology serves as a present and concise compendium to the modern therapeutic developments in the field. This book is likely to benefit clinicians, residents, fellow and other healthcare workers dealing with rheumatological disorders, and also hard-core Rheumatologists, who are looking for a quick recap of Biologics of their interest.
650 0 _aInternal medicine.
650 1 4 _aInternal Medicine.
653 0 _aRheumatic Diseases -- therapy
653 0 _aBiological Therapy
653 6 _aHandbook
700 1 _aJain, Neeraj.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aDuggal, Lalit.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
856 4 0 _uhttps://doi.org/10.1007/978-981-16-7200-2
_3Springer eBooks
_zOnline access link to the resource
942 _2NLM
_cEBK